Value Investing Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Spekulatius who wrote (40513)	2/7/2011 10:29:02 AM
From: E_K_S	of 78918

Good call Spekulatius. I have been watching this one for a long time but never picked up a position. It looks like they got 35% more than when you first posted the article update on 12/10/2010. RE: Beckman Coulter, Inc. Common St(NYSE: BEC ) Feb. 7, 2011, 8:58 a.m. EST Danaher to buy Beckman Coulter for $6.8 billion Investors bid shares of both companies higher marketwatch.com From the article:"...Danaher, a conglomerate that owns the Craftsman hands-tool brand as well as businesses in electronic testing, dental technologies and monitoring products, said Beckman Coulter’s portfolio would complement its existing life-sciences and diagnostics businesses...." -------------------------------------------------------------------- I wonder if the remaining diagnostic companies will carry a premium given the level of interest in this offer? Are there any others you follow? I have a small position in Covidien plc (COV) but they are not really in the diagnostic sector. EKS

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next